Our technology
The damast automaton
Our DAMAST automated system has the potential to revolutionize the way antibiotic susceptibility testing is carried out. Thanks to our patented deep tech technology, we aim to dramatically reduce the time needed to obtain accurate results. Compact and adaptable, DAMAST will be designed to fit perfectly into healthcare facilities, offering optimal use with kits specific to each field of application.
OUR INNOVATION
DAMOCLES Diagnostics has developed a patented technology for the rapid detection of microorganisms. By analyzing bacterial populations by sub-populations according to biophysical criteria such as size and density, our solution can observe up to 10 billion bacteria using a single signal from an integrated spectrophotometer. This method provides an ultra-sensitive and precise reading, rapidly detecting the effects of antimicrobials.
Standard phenotypic technology
- PExtended analysis time (12 to 24 hours)
- PGlobal approach without precise distinction of sub-populations
- PResults dependent on bacterial growth
- PGeneral observation of bacterial behavior in the presence of an antibiotic
DAMOCLES DAMAST technology
- PDiagnosis in minutes. Segmentation by sub-populations (size, density, etc.)
- PAnalysis without the need for bacterial culture (on direct sample), suitable for complex or difficult-to-culture samples
- PPrecise observation of bacterial behavior in the presence of an antibiotic
Signal analysis
Passage from control population (without antimicrobials) :
Passage from control population (with antimicrobials) :